Search

METEOR’s search works in a similar way to other search engines. You can use keywords or terms to pull up related content. The below tips are specific to METEOR and will help you to find what you need.

Try searching using either a keyword, specific term or METEOR ID number.

METEOR ID search

If you’re a returning user and know an item’s METEOR ID, you can enter it in the search box. Clicking the search icon will take you straight to the item’s page.

Autocomplete

METEOR will automatically display suggestions for search terms as you’re typing. This predictive text will show you METEOR entries that exist for the topic you’re searching on. You don’t have to use any of these suggestions, but they may make your searching process faster and easier.

Pressing ‘tab’ will select the top suggestion. Otherwise, selecting from the list of suggestions will put the suggested search term into the search box. You can then click the search icon to find related content. Clicking anywhere on the search results will take you to the item’s page.

Spelling correction

METEOR will show search results with spelling correction. Misspelled terms can still be selected for search where relevant.

Dropdown options

The drop-down menus directly below the search text box allow you to limit the search results to any of the 18 content types in METEOR (see Learn about metadata to view the list), by item creation dates, and item revision dates.

Content types

Content types allow you to limit your search to various metadata building blocks and other topic or help content found in METEOR. See Learn about metadata to view a list of metadata item types that you can search in METEOR. Searching on Topic pages will give results from METEOR’s ‘non-metadata’ pages which explain metadata, how it is managed, how to use METEOR, and how to develop metadata.

Searching on Help will give results from all the pop-up information boxes that are linked to each metadata item. The Help search looks through all text from the METEOR Business Rules, which is accessed through the small ‘i’ icon used throughout the site.

Created date and Revision date

The Created and Revision date dropdown options limit your search to when an item was created or last revised. METEOR will search any time by default, or you can select or specify a custom period.

Custom search syntax

METEOR uses Lucene search syntax. This functionality can be useful to fine-tune your search results even more. Some of the commands include:

  1. Restrict search to the titles of items by using Name: Searchterm. Note that it has to be written exactly as Name, with the capital N. Using name will not work. It doesn’t matter if there’s a space around the colon or not.
  2. Force a second term to be included by using AND.
  3. Widen your search to include another option using the term OR.

For example, if you’re looking for something with the word ‘baby’ in the title you would use Name: baby. METEOR will also give you results for the plural of the search term, so if you search on ‘baby’ you will also get results for ‘babies’. If looking for something with two terms (‘baby’ and ‘admission’) you would use Name: baby AND admission.

Sort by

You can also display your search results with a range of options in the Sort by drop-down menu on the right. You can sort on Relevance, Most/Least Recently Created, Most/Least Recently Updated, and Alphabetically (A–Z and Z–A).

Clear

The Clear button resets the Search page.

Filtering search results

You can fine-tune your search results using the filters that appear in the left-hand menu after searching any term. These filters are dynamic and will only display options specific to your search term, for example, only registration authorities relating to your search term will be displayed. You can use multiple filters at once.

Some of the filters change depending on your role within METEOR. If you are using METEOR without an account, you can search on metadata item type, public registration statuses, METEOR ID, and registration authority. You are also able to compare two items.

If you are using METEOR without an account, you will not be able to save bookmarks for items you’re interested in. There are also some non-public registration statuses that you won’t be able to see.

If you wish to save bookmarks, you can sign up for a free METEOR account easily, just follow the Sign up now prompts after clicking on the Sign In button. If you have an account, you will also be able to subscribe to notifications about changes to specific items in METEOR.

If you are logged in to METEOR as a metadata developer, or any other official role, there are some additional search options. You will be able to restrict your search to the full range of registration status options, including non-public statuses. You will also be able to save bookmarks and subscribe to notifications about changes to items.

Each search result has a small ‘hamburger’ icon on the right . This gives you download links for the metadata item as a PDF or a Word document.


Search

Showing 201-300 of 538 results
Prev 1 2 4 5 6 Next
Page size:
Gynaecological cancer (clinical) NBPDS

599620 | Data Set Specification | Cancer Australia
The purpose of the Gynaecological cancer (clinical) National best practice data set (NBPDS) is to define data standards for the national collection of gynaecological cancer data so that data collected is consistent and reliable. The data set is not mandated for collection but is recommended as best practice if gynaecological cancer data is to be collected. It enables individual treatment centres or health service areas to develop collection methods and policies appropriate for their service. The...
Standard: Health

Gynaecological cancer post-radiotherapy complication indicator

546611 | Property | Cancer Australia
An indicator of the occurrence of treatment complications from radiotherapy for the treatment of gynaecological cancer.
Standard: Health

Gynaecological cancer-related radiotherapy complication type code N

424312 | Value Domain | Cancer Australia
A code set representing types of treatment complications occurring within 30 days of radiotherapy for women with gynaecological cancer.
Standard: Health

Health service event—adverse event grade, code N

467449 | Data Element | Cancer Australia
The grade of an adverse event that has occurred during a health service event as defined by the American National Institute of Health and National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE, v4.0), as represented by a code.
Standard: Health

Healthcare provider—organisation identifier, N(16)

426830 | Data Element | Cancer Australia
The Healthcare provider identifier—organisation (HPI-O) is the numerical identifier that uniquely identifies organisations in Australia where healthcare is provided.
Standard: Health

Hereditary genetic events type

564417 | Property | Cancer Australia
The type of genetic mutation that is passed down to further generations in a biological family.
Standard: Health

Hormone therapy

439580 | Glossary Item | Cancer Australia
The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Hormone therapy completion date

393564 | Property | Cancer Australia
The date on which hormone therapy was completed. Hormone therapy is the treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Hormone therapy for cancer cluster

561324 | Data Set Specification | Cancer Australia
Hormone therapy is cancer treatment that achieves its antitumour effect through changes in hormonal balance. It includes the administration of hormones, agents acting via hormonal mechanisms, antihormones and steroids. The hormone therapy cluster consists of those data elements recommended for collection as best practice when the patient is administered hormone therapy as part of the course of treatment for cancer. The hormone therapy cluster collects information on the hormone therapy agent or ...
Standard: Health

Hormone therapy for cancer cluster

418349 | Data Set Specification | Cancer Australia
Hormone therapy is cancer treatment that achieves its antitumour effect through changes in hormonal balance. It includes the administration of hormones, agents acting via hormonal mechanisms, antihormones and steroids. The hormone therapy cluster consists of those data elements recommended for collection as best practice when the patient is administered hormone therapy as part of the initial course of treatment for cancer. The hormone therapy cluster collects information on the hormone therapy a...
Superseded: Health

Hormone therapy start date

393523 | Property | Cancer Australia
The date on which hormone therapy commenced. The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Identifier N(16)

426832 | Value Domain | Cancer Australia
A unique combination of numbers that identifies an individual or organisation where healthcare is provided within Australia.
Standard: Health

Immediate/short term treatment complication indicator

581057 | Property | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during clinical care.This includes, but is not limited to, complications from surgical treatment, such as an unplanned return to theatre, infection or haemorrhage, or complication from drug treatment, such as hypertension or toxicity.
Standard: Health

Immediate/short-term cancer treatment complication outcome code N

467422 | Value Domain | Cancer Australia
A code set representing the outcomes of immediate or short-term treatment complications relating to cancer treatment.
Standard: Health

Immunohistochemistry type

432940 | Property | Cancer Australia
The type of immunohistochemistry stains used to assist in the identification of abnormal cells.
Standard: Health

Immunotherapy

437322 | Glossary Item | Cancer Australia
The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Immunotherapy completion date

393580 | Property | Cancer Australia
The date on which immunotherapy was completed. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Immunotherapy for cancer cluster

561356 | Data Set Specification | Cancer Australia
Immunotherapy, also known as biological therapy, biotherapy or biological response modifier therapy, is cancer treatment that achieves its antitumour effect by altering the immune system or changing the host's response to the tumour cells. The immunotherapy cluster consists of those data elements recommended for collection as best practice when the patient is administered immunotherapy as part of the course of treatment for cancer. The immunotherapy cluster collects information on the immunother...
Standard: Health

Immunotherapy for cancer cluster

418352 | Data Set Specification | Cancer Australia
Immunotherapy, also known as biological therapy, biotherapy or biological response modifier therapy, is cancer treatment that achieves its antitumour effect by altering the immune system or changing the host's response to the tumour cells. The immunotherapy cluster consists of those data elements recommended for collection as best practice when the patient is administered immunotherapy as part of the initial course of treatment for cancer. The immunotherapy cluster collects information on the im...
Superseded: Health

Immunotherapy start date

393536 | Property | Cancer Australia
The date on which immunotherapy commenced. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Individual Healthcare Identifier

432483 | Property | Cancer Australia
An identifier allocated by Medicare Australia that uniquely identifies each individual in the Australian healthcare system.
Standard: Health

International Federation of Gynecology and Obstetrics cancer staging system

531364 | Classification Scheme | Cancer Australia
The International Federation of Gynecology and Obstetrics cancer staging system is an international system for coding gynaecological cancer, including cervical, endometrial, ovarian and vulval cancer. This system was developed by International Federation of Gynecology and Obstetrics (FIGO) in 1958, and most recently updated in 2009. The two purposes of this system are to allow for comparison of patient treatment and outcomes across both treatment centres and population groups, and to divide pati...
Standard: Health

Late effect indicator

469616 | Property | Cancer Australia
An indicator of whether a late effect appears after the acute stage of a disease or condition has resolved. This is as a result of the treatment, the disease process, or both.
Standard: Health

Late effect type

573455 | Property | Cancer Australia
The type of late effect experienced due to a disease and/or the associated treatment.
Standard: Health

Location of lymphovascular invasion

545101 | Property | Cancer Australia
The location of the invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Lung cancer (clinical) DSS

430950 | Data Set Specification | Cancer Australia
The purpose of the Lung cancer (clinical) data set specification (LCCDSS) is to define data standards for the national collection of lung cancer clinical data so that data collected is consistent and reliable. Collection of this data set specification is not mandated but it is recommended as best practice if clinical cancer data are to be collected. It will facilitate more consistent data collection while enabling individual treatment centres or health service areas to develop data extraction an...
Superseded: Health

Lung cancer (clinical) NBPDS

599613 | Data Set Specification | Cancer Australia
The purpose of the Lung cancer (clinical) National best practice data set (NBPDS) is to define data standards for the national collection of lung cancer clinical data so that data collected is consistent and reliable. Collection of this data set is not mandated but it is recommended as best practice if clinical cancer data are to be collected. It will facilitate more consistent data collection while enabling individual treatment centres or health service areas to develop data extraction and coll...
Standard: Health

Lung cancer diagnostic imaging type code N[N]

429492 | Value Domain | Cancer Australia
A code set representing the type of lung cancer diagnostic imaging performed.
Standard: Health

Lung cancer immunohistochemistry type code N[N]

433010 | Value Domain | Cancer Australia
A code set representing immunohistochemical stains used to assist in the diagnosis of lung cancer.
Standard: Health

Lung cancer molecular pathology test results code N[N]

432920 | Value Domain | Cancer Australia
A code set representing the genetic or molecular abnormalities detected in lung cancer molecular pathology testing.
Standard: Health

Lung cancer surgical margin qualifier code N[N]

433048 | Value Domain | Cancer Australia
A code set representing the surgical margin closest to the invasive or in situ lung carcinoma.
Standard: Health

Lymphovascular invasion code N

430724 | Value Domain | Cancer Australia
A code set representing the type of lymphovascular invasion present.
Standard: Health

Lymphovascular invasion indicator

519205 | Property | Cancer Australia
An indicator of whether there is evidence of the invasion of cancer cells into blood vessels and/or the lymphatic system in the pathology specimen.
Standard: Health

Lymphovascular invasion of cervix code N

424173 | Value Domain | Cancer Australia
A code set representing the location of tumour invasion into the lymphatic and/or vascular space for patients with cervical cancer.
Standard: Health

Lymphovascular invasion of corpus uteri code N

424443 | Value Domain | Cancer Australia
A code set representing the location of tumour invasion into the lymphatic and/or vascular space for patients with cancer of the corpus uteri.
Standard: Health

Lymphovascular invasion type

430038 | Property | Cancer Australia
The type of invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Macroscopic

545389 | Glossary Item | Cancer Australia
Large enough to be seen with the naked eye. For example, a macroscopic tumour is able to be seen without the aid of a microscope.
Standard: Health

Medical specialist—surgical specialty, initial gynaecological surgical speciality code N[N]

424298 | Data Element | Cancer Australia
The medical specialty of the surgeon who performed surgery for gynaecological cancer treatment, as represented by a code.
Standard: Health

Molecular pathology indicator

435162 | Property | Cancer Australia
An indicator of whether molecular pathology testing was performed to determine the characteristics of a person's medical condition.
Standard: Health

Molecular pathology test date

519350 | Property | Cancer Australia
The date on which a molecular pathology test is performed to determine the characteristics of a person's medical condition.
Standard: Health

Molecular pathology test results

428389 | Property | Cancer Australia
The results of a molecular pathology test for genetic and molecular abnormalities. In a clinical environment these results will inform the appropriate patient treatment pathway.
Standard: Health

Molecular test results (other) code X[X(19)]

450481 | Value Domain | Cancer Australia
The gene symbol representing the genetic or molecular abnormalities detected in a person, other than those already specified.
Standard: Health

Multidisciplinary team review indicator

428242 | Property | Cancer Australia
An indicator of whether a patient's treatment was discussed and planned at a multidisciplinary team meeting. The multidisciplinary team should consist of the core disciplines required for the provision of good patient care, which will vary by disease type.
Standard: Health

Multiple primary tumours descriptor

433391 | Property | Cancer Australia
Whether the multiple primary tumours in the person with cancer are synchronous or metachronous. Synchronous primary tumours are detected simultaneously, either preoperatively or in the resected specimen. Metachronous primary tumours are detected after a time interval between detection of the first lesion and detection of a subsequent primary lesion.
Standard: Health

Multiple primary tumours descriptor code N

429470 | Value Domain | Cancer Australia
A code set representing the type of multiple primary tumours.
Standard: Health

Multiple primary tumours indicator

519542 | Property | Cancer Australia
An indicator of whether multiple primary tumours are present.
Standard: Health

Myometrial thickness

545252 | Property | Cancer Australia
The total thickness of the myometrium, i.e. the middle layer of tissue in the uterine wall.
Standard: Health

Nanograms per millilitre

481446 | Value Domain | Cancer Australia
The number of nanograms per millilitre.
Standard: Health

Other cancer treatment

403842 | Property | Cancer Australia
Treatments used for the treatment of cancer other than surgery, radiotherapy or systemic therapy.
Standard: Health

Other cancer treatment text X[X(149)]

409006 | Value Domain | Cancer Australia
The cancer-directed treatment administered to the patient that cannot be defined as surgery, radiotherapy or systemic therapy.
Standard: Health

Outcome of treatment code N.N

561646 | Value Domain | Cancer Australia
A code set representing the response of the tumour at the completion of treatment.
Standard: Health

Outcome of treatment code N.N

402051 | Value Domain | Cancer Australia
A code set representing the response of the tumour at the completion of treatment.
Superseded: Health

Patient—cancer status, code N

394071 | Data Element | Cancer Australia
The absence or presence of clinical evidence of cancer in the patient, as represented by a code.
Standard: Health

Patient—date of last contact, DDMMYYYY

394060 | Data Element | Cancer Australia
The date of last contact with the patient, expressed as DDMMYYYY.
Standard: Health

Patient—diagnosis date of cancer

447726 | Data Element Concept | Cancer Australia
The date on which the patient was diagnosed with cancer.
Standard: Health

Patient—diagnosis date of cancer, DDMMYYYY

416129 | Data Element | Cancer Australia
The date on which the patient was first diagnosed with cancer (whether at its primary site or as a metastasis), expressed as DDMMYYYY.
Standard: Health

Patient—diagnosis date of first recurrence as distant metastasis

447728 | Data Element Concept | Cancer Australia
The date on which a patient is diagnosed with the first recurrence as a distant metastasis of the same histology as the primary cancer.
Standard: Health

Patient—diagnosis date of first recurrence as distant metastasis, DDMMYYYY

393841 | Data Element | Cancer Australia
The date on which a patient is diagnosed with the first recurrence as a distant metastasis of the same histology as the primary cancer, expressed as DDMMYYYY.
Standard: Health

Patient—diagnosis date of first recurrence as locoregional cancer

447731 | Data Element Concept | Cancer Australia
The date on which a patient is diagnosed with the first recurrence as locoregional cancer of the same histology as the primary cancer.
Standard: Health

Patient—diagnosis date of first recurrence as locoregional cancer, DDMMYYYY

393837 | Data Element | Cancer Australia
The date on which a patient is diagnosed with the first recurrence as locoregional cancer of the same histology as the primary cancer, expressed as DDMMYYYY.
Standard: Health

Patient—immediate/short term treatment complication indicator

581054 | Data Element Concept | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during a patient's medical treatment.
Standard: Health

Patient—immediate/short term treatment complication indicator, yes/no/not applicable/unknown/not stated/inadequately described code N

467430 | Data Element | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during the patient's medical treatment, as represented by a code.
Standard: Health

Patient—treatment complication date

467420 | Data Element Concept | Cancer Australia
The date that a treatment complication (adverse event) is experienced by a patient during or after medical treatment.
Standard: Health

Patient—treatment complication date, DDMMYYYY

467440 | Data Element | Cancer Australia
The date that a treatment complication (adverse event) is experienced by a patient during or after medical treatment, expressed as DDMMYYYY.
Standard: Health

Pelvic lymph node dissection indicator

587594 | Property | Cancer Australia
An indicator of the occurrence of a pelvic lymph node dissection. Pelvic lymph node dissection is completed for the purpose of determining lymph node metastasis in cancer. This procedure is most commonly used in prostate and bladder cancers.
Standard: Health

Pelvic lymph node dissection laterality

494382 | Property | Cancer Australia
The laterality of the dissection of a pelvic lymph node for the purpose of determining lymph node metastasis in cancer. This procedure is most commonly used in prostate and bladder cancers.
Standard: Health

Performance status score at diagnosis

412353 | Property | Cancer Australia
A score given at the time of diagnosis outlining the extent to which a person’s disease affects their daily living abilities. This is based on assessment by a treating health professional. Performance status at diagnosis is an important prognostic indicator which is used to determine appropriate treatment, assess how the disease has progressed, and for the statistical analyses of outcome adjusted by performance status.
Standard: Health

Perineural invasion indicator

429128 | Property | Cancer Australia
An indicator of whether perineural invasion is evident in a pathology specimen.Perineural invasion refers to cancer cells tracking along or around a nerve within the space surrounding a nerve.
Standard: Health

Person with cancer—adolescent and young adult cancer healthcare provider type, code N[N]

457925 | Data Element | Cancer Australia
The type of healthcare provider (individual, team or organisation) that is providing primary care to an adolescent or young adult with cancer, as represented by a code.
Standard: Health

Person with cancer—basis of diagnostic investigation, code N

431369 | Data Element | Cancer Australia
The basis of diagnostic investigation of a person with cancer at the time of first presentation, as represented by a code.
Standard: Health

Person with cancer—biopsy core number

587606 | Data Element Concept | Cancer Australia
The number of biopsy cores from a single specimen pot examined as part of pathology testing of tissue from a person with cancer.
Standard: Health

Person with cancer—biopsy core, number N[NN]

490884 | Data Element | Cancer Australia
The number of biopsy cores from a single specimen provided for examination as part of pathology testing of tissue from a person with cancer, presented as a number.
Standard: Health

Person with cancer—cancer healthcare provider type

457920 | Data Element Concept | Cancer Australia
The type of healthcare provider (individual, team or organisation) that is providing primary care to the person with cancer.
Standard: Health

Person with cancer—care coordinator assignment indicator

467846 | Data Element Concept | Cancer Australia
An indicator of whether a care coordinator has been assigned to the person with cancer.
Standard: Health

Person with cancer—care coordinator assignment indicator, yes/no/pending code N

467848 | Data Element | Cancer Australia
An indicator of whether a care coordinator has been assigned to the person with cancer, as represented by a code.
Standard: Health

Person with cancer—castrate resistance date

587561 | Data Element Concept | Cancer Australia
The date that two consecutive rising prostate-specific antigen levels (PSA) were found despite castrate levels of testosterone in a person with cancer.
Standard: Health

Person with cancer—castrate resistance date, DDMMYYYY

492865 | Data Element | Cancer Australia
The date on which two consecutive rising prostate-specific antigen (PSA) levels were found despite castrate levels of testosterone in a person with cancer, expressed as DDMMYYYY.
Standard: Health

Person with cancer—castrate resistance indicator

492863 | Data Element Concept | Cancer Australia
An indicator of whether a rising prostate-specific antigen (PSA) level, or continued progression of prostate cancer despite castrate levels of testosterone (<50ng/dL) has been found, in a person with cancer.
Standard: Health

Person with cancer—castrate resistance indicator, yes/no code N

492869 | Data Element | Cancer Australia
An indicator of whether a person with cancer has been found to have castrate resistance, as represented by a code.
Standard: Health

Person with cancer—clinical trial entry status

430025 | Data Element Concept | Cancer Australia
The status of clinical trial acceptance for the person with cancer.
Standard: Health

Person with cancer—clinical trial entry status, code N

430028 | Data Element | Cancer Australia
The status of clinical trial acceptance for the person with cancer, as represented by a code.
Standard: Health

Person with cancer—clinical trial experimental agent or intervention

487334 | Data Element Concept | Cancer Australia
The experimental agent or intervention used in a clinical trial for the treatment or management of cancer.
Standard: Health

Person with cancer—clinical trial experimental agent or intervention, text X[X(399)]

487311 | Data Element | Cancer Australia
The experimental agent or intervention used in a clinical trial for the treatment or management of cancer, as represented in text.
Standard: Health

Person with cancer—clinical trial funding basis, code N

467780 | Data Element | Cancer Australia
The funding basis of a clinical trial entered by the person with cancer, whether academic and/or industry funded, as represented by a code.
Standard: Health

Person with cancer—clinical trial identifier, text X[X(399)]

430953 | Data Element | Cancer Australia
The scientific/public title and/or registration number of the clinical trial(s) in which the person with cancer is enrolled, as represented by text.
Standard: Health

Person with cancer—clinical trial phase, code N

458384 | Data Element | Cancer Australia
The phase of the clinical trial(s) in which the person with cancer is enrolled, as represented by a code.
Standard: Health

Person with cancer—comorbidities, code N[N]

458075 | Data Element | Cancer Australia
The type of comorbidities present at the time of diagnosis of cancer, expressed as a code.
Recorded: Health

Person with cancer—comorbidities, Colinet defined comorbidities code N[N]

432994 | Data Element | Cancer Australia
Diseases or conditions present at diagnosis and defined as comorbidities relevant to non-small cell lung cancer by Colinet et al 2005, as represented by a code.
Standard: Health

Person with cancer—comorbidities, text X[X(99)]

463562 | Data Element | Cancer Australia
A comorbidity present in the person with cancer at the time of cancer diagnoses, as represented by text.
Standard: Health

Person with cancer—core biopsy length

587534 | Data Element Concept | Cancer Australia
The total length of biopsy cores collected from a single tissue specimen in pathology testing of a tissue from a person with cancer.
Standard: Health

Person with cancer—core biopsy length, total millimetres NN.N

490968 | Data Element | Cancer Australia
The total length of biopsy cores collected from a single tissue specimen in pathology testing of a tissue from a person with cancer, represented by a code.
Standard: Health

Person with cancer—core biopsy tumour extent

587553 | Data Element Concept | Cancer Australia
The extent of tissue involved by cancer cells in a single specimen found in pathology testing of tissue from a person with cancer.
Standard: Health

Person with cancer—core biopsy tumour extent, percentage N[NNN]

513455 | Data Element | Cancer Australia
The extent of tissue involved by cancer cells in a single specimen found in pathology testing of tissue from a person with cancer, presented by a percentage.
Standard: Health

Person with cancer—core biopsy tumour length

587545 | Data Element Concept | Cancer Australia
The total length of tissue involved by cancerous tissue in a single specimen found in pathology testing of tissue from a person with cancer.
Standard: Health

Person with cancer—core biopsy tumour length, total millimetres NN.N

513447 | Data Element | Cancer Australia
The total length of tissue involved by cancerous tissue in a single specimen found in pathology testing of tissue from a person with cancer, presented in millimetres.
Standard: Health

Person with cancer—cytopathology result

422466 | Data Element Concept | Cancer Australia
The result of a cytopathology test to verify cancer diagnosis and morphology in a person with cancer.
Standard: Health

Person with cancer—cytopathology result, code N

422463 | Data Element | Cancer Australia
The result of a cytopathology test to verify cancer diagnosis and morphology in a person with cancer, as represented by a code.
Standard: Health

Person with cancer—date clinical trial completed

482208 | Data Element Concept | Cancer Australia
The date on which a clinical trial for the treatment of person with cancer is completed.
Standard: Health

Person with cancer—date clinical trial completed, DDMMYYYY

482206 | Data Element | Cancer Australia
The date on which a clinical trial for the treatment of person with cancer is completed, expressed as DDMMYYYY.
Standard: Health

Person with cancer—date clinical trial entered, DDMMYYYY

447247 | Data Element | Cancer Australia
The date on which a person with cancer registers for a clinical trial, expressed as DDMMYYYY.
Standard: Health

Prev 1 2 4 5 6 Next
Page size: